Yoshihiro Kawaoka Quotations

only one case, and whether that condition was something unique we don't know.

By reducing the number of plasmids, we increase the efficiency of virus production,

We don't know how many more mutations are required. But at this point, we still have some time.

We don't know how frequently this kind of mutation can appear,

I don't think we need to panic based on this finding.

Our findings provide a rational explanation for why H 5 N 1 viruses rarely infect and spread from human to human, although they can replicate efficiently in the lungs.

In that context, this is an important drug.

This is the first line of defense. It is the drug many countries are stockpiling, and the plan is to rely heavily on it.

Application of the new system may be especially advantageous in situations of outbreaks of highly pathogenic avian influenza viruses.

Patient 1 had not had any known direct contact with poultry, but had cared for her 21-year-old brother (patient 2) while he had a documented H5N1 virus infection,